Editorial Comment: Beyond the Surface ECG: Can the CLAP Score Improve Recognition of Concealed Left-Sided Accessory Pathways?
Pakistan Heart Journal · 2026-10-31 · 59 (5) · 1703-1705
DOI: 10.47144/phj.v59i5.4041 ↗Abstract
Although the 12-lead electrocardiogram (ECG) remains central to the evaluation of regular narrow-complex tachycardia, distinguishing atrioventricular nodal reentrant tachycardia (AVNRT) from orthodromic atrioventricular reentrant tachycardia (AVRT) can be challenging. Concealed accessory pathways are particularly difficult to recognize because pre-excitation is absent during sinus rhythm, leaving the tachycardia ECG as an important source of diagnostic clues. Anticipating the likely mechanism and a possible left-sided pathway before an electrophysiological study (EPS) may assist procedural planning. The key, however, is to translate surface ECG findings into useful estimates of probability without treating them as definitive evidence [1,2]. In this issue of Pakistan Heart Journal, Hyder and colleagues introduce the Concealed Left-sided Accessory Pathway (CLAP) score, derived from 290 adults undergoing EPS for narrow-complex tachycardia at the National Institute of Cardiovascular Diseases, Karachi. EPS identified AVNRT in 238 patients (82.1%), left-sided AVRT in 29 (10.0%), right-sided AVRT in 12 (4.1%), and non-inducible tachycardia in 11 (3.8%). The six-point score incorporates four ECG features: an intermediate RP interval (>90 ms and shorter than the PR interval; two points), absence of a pseudo-R′ wave in lead V1 (two points), ST-segment depression (one point), and a heart rate >200 beats/minute (one point). At a cutoff of four points, the reported sensitivity was 79.3%, specificity 88.5%, positive predictive value 43.4%, and negative predictive value 97.5%. The area under the receiver operating characteristic curve was 0.938, with a similar optimism-corrected estimate following bootstrap validation [3]. The study addresses a clinically relevant question using a widely accessible, low-cost investigation and an invasive electrophysiological reference standard. Consecutive recruitment and blinded ECG assessment are additional strengths. The proposed predictors also have a plausible electrophysiological basis: a pseudo-R′ wave in V1 may reflect near-simultaneous atrial and ventricular activation in typical AVNRT, whereas a more distinct retrograde atrial signal and longer RP interval can favor AVRT. Nevertheless, these features primarily inform the likely tachycardia mechanism; they do not, by themselves, establish that an accessory pathway is left-sided [1,2]. The apparently strong discrimination warrants cautious interpretation. Only 29 participants had the target outcome, limiting the number of events available for multivariable modelling and increasing the risk of imprecise estimates. For example, the adjusted odds ratio for absence of a pseudo-R wave was 16.14, but the 95% confidence interval ranged widely from 1.95 to 133.27. ST-segment depression and heart rate >200 beats/minute were retained in the simplified score despite not independently reaching conventional statistical significance. Although bootstrap validation can estimate optimism within the development dataset, it does not establish performance across other centres, patient populations, or clinical settings. The authors therefore appropriately characterize CLAP as exploratory [3,4]. Clinical interpretation also depends on the predictive values. With a 10% prevalence of left-sided AVRT in this cohort, the positive predictive value at a threshold of four points was 43.4%, meaning that more than half of patients with a positive score did not have the target diagnosis. Conversely, the high negative predictive value partly reflects the relatively low prevalence of left-sided AVRT. The comparator group included patients with AVNRT, right-sided AVRT, and non-inducible tachycardia. While appropriate for the study’s stated population, this design evaluates discrimination of left-sided AVRT from a mixture of alternative outcomes, not precise localization of accessory pathways among patients with confirmed AVRT. Reproducibility is another concern. Pseudo-R′ waves, subtle retrograde P waves, and ST-segment depression may be difficult to assess on rapid or artifact-affected ECG recordings, particularly outside specialized electrophysiology units. Although two electrophysiologists interpreted the tracings, formal interobserver agreement was not available. Moreover, classifying the 11 patients with non-inducible tachycardia as outcome-negative introduces some diagnostic uncertainty, notwithstanding assessment during ventricular pacing. These issues should be addressed before assuming that the score will perform similarly when applied by emergency physicians, general cardiologists, trainees, or teams in other institutions [3]. In Pakistani electrophysiology practice, the most plausible near-term role of CLAP is to inform anticipation rather than dictate management. A higher score may encourage careful review of retrograde atrial activation and preparation for possible left-sided mapping or access. It should not determine the choice of transseptal versus retrograde aortic access, replace standard pacing manoeuvres, or override intracardiac findings. Likewise, a low score cannot reliably exclude an accessory pathway when other evidence supports its presence. Importantly, the study did not assess whether use of CLAP reduces procedure duration, fluoroscopy exposure, complications, or costs [2,3]. Prospective external validation is now essential, ideally across institutions with varying referral patterns, expertise, and patient case mixes. Such studies should prespecify score thresholds, report confidence intervals and calibration, and quantify interobserver agreement. Comparisons with expert ECG interpretation and simpler models would help establish whether all four components provide meaningful incremental value. Ultimately, implementation research should determine whether access to the score improves procedural readiness, decision-making, or patient outcomes rather than merely statistical discrimination [4]. The CLAP study represents a valuable contribution to locally generated electrophysiology research. Its principal achievement is not the creation of a definitive diagnostic rule but the systematic evaluation of readily available ECG clues against invasive findings. For now, the most appropriate message is to use the surface ECG to refine clinical suspicion while relying on established electrophysiological manoeuvres to confirm the mechanism and pathway location. References Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, Blomström-Lundqvist C, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J. 2020;41(5):655-720. DOI: 10.1093/eurheartj/ehz467 Katritsis DG, Boriani G, Cosio FG, Hindricks G, Jaïs P, Josephson ME, et al. European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias. Europace. 2017;19(3):465-511. DOI: 10.1093/europace/euw301 Hyder A, Amer K, Baig A, Qayoom R, Mumtaz Z, Ansari MS, et al. Electrocardiographic predictors of concealed left-sided accessory pathways in patients with narrow-complex tachycardia: development and internal validation of the CLAP score. Pak Heart J. 2026;59(5):1691-1702. DOI: 10.47144/phj.v59i5.3923 Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med. 2015;162(1):55-63. DOI: 10.7326/M14-0697
EUVIMED